Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children

Anticancer Research

Volumn 19, Issue 2 B, 1999, Pages 1451-1454

  Skotnicka Klonowicz, Grazyna ^a   Rieske, Piotr ^b   Bartkowiak, Jacek ^b   Szymik Kantorowicz, Sabina ^b   Daszkiewicz, Pawel ^b   Debiec Rychter, Maria ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

Loss of heterozygosity of WT1; Prognostic value; Sporadic Wilms' tumour

Indexed keywords

MICROSATELLITE DNA; PARAFFIN;

ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INFANT; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HETEROZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RISK FACTORS; TRANSCRIPTION FACTORS; WILMS TUMOR; WT1 PROTEINS;

EID: 0032994263     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Birch JM: L'epidemiologie du cancer chez l'enfant. Annales Nestle. Oncologie pediatrique, 48: 3, 113-125, 1990.
2. Breslow NE, Olshan A, Beckwith JB, Green DM: Epidemiology of Wilms' Tumour. Med Pediatr Oncol 21: 172-181, 1993.
3. Coppes MJ, Haber DA, Grundy PE: Genetic Events in the Development of Wilms' Tumour. New Engl J Med 331: 586-590, 1994.
4. Schmidt D, Beckwith JB: Histopathology of Childhood Renal Tumours. Hematology/Oncology Clinics of North America 9: 6, 1179-1200, 1995.
5. Miller RW, Fraumeni JF, Hanning MD: Association of Wilms' Tumour with Aniridia, Hemihypertrophy and Other Congenital Malformations. New Engl J Med 270: 922-927, 1964.
6. Bonaiti - Pellie C, Chompret A, Tournade MF, Hocher J, Mouton C, Zucker JM: Genetics and Epidemiology of Wilms' Tumour the French Wilms' Tumour Study. Med Pediatr Oncol 20: 284-291, 1992.
7. Clericuzio C: Clinical Phenotypes and Wilms' Tumour. Med Pediatr Oncol 21: 182-187, 1993.
8. Betts DR, Koesters R, Pluss HJ, Wiggli FK: Rutine Karyotyping in Wilms Tumour. Cancer Genet Cytogenet 96: 151-156, 1997.
9. Grundy PE, Coppes M: An Overview of the Clinical and Molecular Genetics of Wilms' Tumour. Med Pediatr Oncol 27: 394-397, 1996.
10. Huff V Genotype/Phenotype Correlations in Wilms' Tumour. Med Pediatr Oncol 27: 408-414, 1996.
11. Knudson AG Jr: Introduction to the Genetics of Primary Renal Tumours in Children. Med Pediatr Oncol 21: 193-198, 1993.
12. Koo MP, Hensle TW: Molecular Biology of Wilms Tumour. Urologic Clinics of North America. 20: 2, 323-331, 1993.
13. Weksberg R, Squire J: Molecular Biology of Beckwith-Wiedemann Syndrome. Med Pediatr Oncol 27:462-469, 1996.
14. Kondo K, Chilcate RR, Maurer HS, Rowley JD: Chromosome Abnormalities in Tumour Cell from Patients with Sporadic Wilms' Tumour. Cancer Res 44: 5376-5381, 1984.
15. Grundy PE Coppes M, Haber D: Molecular Genetics of Wilms' Tumour. Hematology/Oncology Clinics of North America 9: 6, 1201-1215, 1995.
16. Altura RA, Valentine M, Li H, Boyett JM, Shearer P, Grundy PE, Shapiro DM, Look AT: Identification of Novel Regions of Deletion in Familial Wilms' Tumour by Comparative Genomic Hybridization. Cancer Res 56: 3837-41, 1996.
17. Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, Manneus M, Callen D, Junien C, Jeanpierre C: Characterisation of Regions of Chromosomes 12 and 16 Involved in Nephroblastoma Tumourigenesis. Genes. Chromosom Cancer 14: 285-294, 1995.
18. Cawkwell L, Lewis FA, Quirke P: Frequency of Allele Loss of DDC, p53, RB 1, NF 1, NM23 and APC/MCC in Colorectal Cancer by Fluorescent Multiplex Polymerase Chain Reaction. Br J Cancer 70: 813-818, 1994.
19. Kitlinska J, Wojcierowski J: Zaburzenia genomowe w nowotworach jelita grubego. Polski Przeglad Chirurgiczny 7: 740-746, 1997.
20. Limon J, Mitelman F: Znaczenie aberracji chromosomowych w litych guzach nowotworowych czlowieka. Patologia Polska 45: 1, 1-15, 1994.
21. Pritchard-Jones K, Fleming S, Dawidson D, Bickmore W, Parteon SD, Gosden C, Bard J, Buckler A, Pelletier J, Housman DE, van Deyingen V, Hastie N: The Candidate Wilms' Tumour Gene Is Involved in Genitourinary Development. Nature 346: 194-197, 1990.
22. Kaneko Y, Homma Ch, Maseki N, Sakurai M, Hata J: Correlation of Chromosome Abnormalities with Histological and Clinical Features in Wilms' and Other Childhood Renal Tumours'. Cancer Res 51: 5937-5942, 1991.
23. Grundy PE, Telzerow P, Moksness JZ, Breslow NE: Clinicopathologic Correlates of Loss of Heterozygosity in Wilms' Tumour. A Preliminary Analysis. Med Pediatr Oncol 27: 429-433, 1996, 11
24. Knudson AG, Strong LC: Mutation and Cancer: A model for Wilms' Tumour of the Kidney. J Natl Cancer Inst 48: 313-324, 1972.
25. Pelletier J, Bruening W, Kashtan C, Mauer S, Manivel J, Striegel J, Houghton D, Junien C, Habib R, Fouser L, Fine R, Silverman B, Haber DA, Housman DE: Germline Mutations in the Wilms' Tumour Suppressor Gene Are Associated with Abnormal Urogenital Development in Denys-Drash Syndrom. Cell 67: 437-447, 1991.
26. Birch JM, Breslow NE: Epidemiologic Features of Wilms' Tumour. Hematology/Oncology Clinics of North America 9: 6, 1157-1177, 1995.
27. Green DM, Thomas PRM, Shochat S: The Treatment of Wilms' Tumour. Results of the National Wilms' Tumour Studies. Hematolog/Onkolog Clinics of North America 9: 6, 1267-1273, 1995.
28. Leczenie nerczaka u dzieci, Zalecenia Polskiej Grupy Pediatrycznej ds. Leczenia Guzow Litych. Protokol 92-01 pod red. K. Sawicz-Birkowskiej.
29. Lemerle J, Tournade MF: Nephroblastoma (Tumeur de Wilms). Rev Prat Paris 43: 17, 2192-96, 1993.
30. Tournade MF, de Kraker J, Lemerle J, Carli M, Zucker JM, Burgers JMV, Voute PA: Preoperative Chemotherapy of Patients over 6 Months of Age with a Nephroblastoma: A report ofthe SIOP Wilms' Tumour Trials and Studies. Med Pediatr Oncol 23: 3, 171, 1994.
31. Zhuang Z, Merino MF, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS: Identical Genetic Changes in Different Histologic Components of Wilms' Tumours. J Natl Cancer Inst Aug 6: 89 (15), 1148-52, 1997.